A detailed history of Antipodes Partners LTD transactions in Hca Healthcare, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 362,179 shares of HCA stock, worth $171 Million. This represents 3.81% of its overall portfolio holdings.

Number of Shares
362,179
Previous 391,458 7.48%
Holding current value
$171 Million
Previous $150 Million 2.93%
% of portfolio
3.81%
Previous 4.99%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$334.32 - $426.2 $9.79 Million - $12.5 Million
-29,279 Reduced 7.48%
362,179 $154 Million
Q2 2025

Aug 04, 2025

SELL
$317.61 - $387.52 $14 Million - $17 Million
-43,965 Reduced 10.1%
391,458 $150 Million
Q1 2025

May 06, 2025

BUY
$296.7 - $345.55 $121 Million - $141 Million
406,682 Added 1414.99%
435,423 $150 Million
Q4 2024

Feb 10, 2025

BUY
$297.52 - $415.61 $8.55 Million - $11.9 Million
28,741 New
28,741 $8.63 Million

Others Institutions Holding HCA

About HCA Healthcare, Inc.


  • Ticker HCA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 287,024,992
  • Market Cap $136B
  • Description
  • HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surger...
More about HCA
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.